Status:

COMPLETED

Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents

Lead Sponsor:

Sanofi Pasteur, a Sanofi Company

Conditions:

Meningococcal Immunisation

Healthy Volunteers

Eligibility:

All Genders

10-25 years

Phase:

PHASE1

PHASE2

Brief Summary

The purpose of VAN00010 study is to assess the safety and immunogenicity of the investigational pentavalent meningococcal ABCYW vaccine in adults and adolescents. The study duration will be up to 12 ...

Detailed Description

The study duration will be approximately 12 months for all participants

Eligibility Criteria

Inclusion

  • Aged 18 to 25 years or 10 to 17 years on the day of inclusion
  • Participants who are overtly healthy as determined by medical evaluation including medical history, physical examination, and judgment of the Investigator.
  • Participants who are either unvaccinated with MenACWY vaccine or have received a single previous dose of MenACWY vaccine at least 4 years prior to study enrollment

Exclusion

  • Participants are excluded from the study if any of the following criteria apply:
  • Known or suspected congenital or acquired immunodeficiency
  • History of any Neisseria meningitidis infection
  • At high risk for meningococcal infection during the study
  • Individuals with active tuberculosis
  • History of Guillain-Barré syndrome
  • Alcohol, prescription drug, or substance abuse that, in the opinion of the Investigator, might interfere with the study conduct or completion NOTE: The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Key Trial Info

Start Date :

October 31 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 21 2025

Estimated Enrollment :

1215 Patients enrolled

Trial Details

Trial ID

NCT06128733

Start Date

October 31 2023

End Date

July 21 2025

Last Update

August 29 2025

Active Locations (47)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 12 (47 locations)

1

Accel Research Site - Birmingham Clinical Research Unit- Site Number : 8400080

Birmingham, Alabama, United States, 35216

2

Lakeview Clinical Research Site Number : 8400029

Guntersville, Alabama, United States, 35976-2206

3

Alliance for Multispecialty Research- Phoenix- Site Number : 8400056

Tempe, Arizona, United States, 85281

4

Harrisburg Family Medical Center Site Number : 8400070

Harrisburg, Arkansas, United States, 72432